Responses
Clinical science
Original article
A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus
Compose a Response to This Article
Other responses
No responses have been published for this article.